Article

Santen moving

Santen Inc. is moving its U.S. corporate headquarters from Napa, CA, to Emeryville, CA, in July.

Napa, CA-Santen Inc. is moving its U.S. corporate headquarters from Napa, CA, to Emeryville, CA, in July. The company is a wholly-owned subsidiary of Santen Pharmaceutical Co., Ltd., Osaka, Japan.

“In the preparation of our new strategic plan, we can see that there will be substantial expansion of the organization, and we could not have accommodated this growth in the existing facility in Napa,” said Akihiro Tsujimura, chief operating officer of Santen Inc. “Since we will experience a significant demand for new staff, we believe that the new location will make it easier to recruit the highest-quality talent, as we will have increased access to the greater San Francisco Bay area biopharmaceutical talent pool.”

A secondary reason for the relocation, according to company officials, was the need for convenient access to international transportation due to increased interaction with the company’s employees in Japan and Europe.

Santen will occupy nearly 50,000 square feet on the top two floors of a 16-story building.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.